Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06257706
What this trial is testing

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn's DiseaseCrohn DiseaseDisease Crohn
Alimentiv Inc. 304
Large-scale testing (Phase 3)Study completedNCT04205643
What this trial is testing

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Who this might be right for
Ulcerative Colitis
Celltrion 548
Testing effectiveness (Phase 2)Ended earlyNCT00792740
What this trial is testing

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Italfarmaco 51
Testing effectiveness (Phase 2)Study completedNCT01988961
What this trial is testing

Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 103
Large-scale testing (Phase 3)WithdrawnNCT04643483
What this trial is testing

Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Biopharma SRL
Early research (Phase 1)Study completedNCT02148185
What this trial is testing

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 1
Large-scale testing (Phase 3)Study completedNCT00206674
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 286
Not applicableNot Yet RecruitingNCT07358923
What this trial is testing

Accuracy of Modified Milan Ultrasound Criteria in Assessing Disease Activity and Severity in Moderate-to-Severe Ulcerative Colitis: a Pilot Study

Who this might be right for
Ulcerative Colitis (UC)
IRCCS San Raffaele 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04033445
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Janssen Research & Development, LLC 1,064
Not applicableEnded earlyNCT05069259
What this trial is testing

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

Who this might be right for
Ulcerative Colitis
Pfizer 18
Post-approval studies (Phase 4)Ended earlyNCT05369832
What this trial is testing

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 139
Testing effectiveness (Phase 2)Study completedNCT06049017
What this trial is testing

JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 252
Testing effectiveness (Phase 2)WithdrawnNCT04209556
What this trial is testing

Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer
Testing effectiveness (Phase 2)Study completedNCT03681067
What this trial is testing

A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
University of Birmingham 5
Testing effectiveness (Phase 2)Study completedNCT01336465
What this trial is testing

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 124
Early research (Phase 1)Study completedNCT05084261
What this trial is testing

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Adiso Therapeutics 24
Large-scale testing (Phase 3)Looking for participantsNCT06227910
What this trial is testing

Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 396
Testing effectiveness (Phase 2)Study completedNCT03395184
What this trial is testing

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Pfizer 244
Testing effectiveness (Phase 2)Ended earlyNCT01659138
What this trial is testing

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sanofi 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177835
What this trial is testing

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 203
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation